Angle (AGL)

Sector:

Support

Index:

FTSE AIM All-Share

9.60p
   
  • Change Today:
      0.25p
  • 52 Week High: 31.35
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 322.64m
  • Volume: 352,309
  • Market Cap: £30.97m
  • RiskGrade: 312
  • Beta: 0.73

Angle Overview

ANGLE is a world leading liquid biopsy company with sample to answer solutions. ANGLE’s proven patent protected platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.

1 Day Chart (24-12-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -995.4% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 14.2 n/a
Pr/Book 1.4  
Latest F'cast
Revenue 110.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Angle Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.58 (9.04) (4.61)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.76 (13.74) (6.51)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.01 (17.36) (6.66)p n/a n/a n/a n/a 0.0%
31-Dec-22 1.04 (24.44) (8.96)p n/a n/a n/a n/a 0.0%
31-Dec-23 2.19 (21.63) (7.72)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Angle Company Announcements

Half-year Report 26-Sep-2024 07:00 RNS
Exclusive agreement for DNA NGS panel 23-Sep-2024 07:00 RNS
Notice of Interim Results and Webcast 17-Sep-2024 07:00 RNS

Angle ShareCast News

Angle signs new agreement US biotech Recursion 19-Sep-2024 ShareCast
Angle unveils plans to raise more than £10m 05-Jun-2024 ShareCast
Angle reports promising results from Parsortix s... 16-May-2024 ShareCast

Angle Top Newspaper Links

New Angle for Braveheart 26-Jan-2009 The Scotsman

Latest Angle Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Angle Market Data

Currency UK Pounds
Share Price 9.60p
Change Today 0.25p
% Change 2.67 %
52 Week High 31.35
52 Week Low 7.25
Volume 352,309
Shares Issued 322.64m
Market Cap £30.97m
Beta 0.73
RiskGrade 312

Angle Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.53% below the market average40.53% below the market average40.53% below the market average40.53% below the market average40.53% below the market average
25.27% above the sector average25.27% above the sector average25.27% above the sector average25.27% above the sector average25.27% above the sector average
Price Trend
69.31% below the market average69.31% below the market average69.31% below the market average69.31% below the market average69.31% below the market average
74% below the sector average74% below the sector average74% below the sector average74% below the sector average74% below the sector average
Income Not Available
Growth
57.38% above the market average57.38% above the market average57.38% above the market average57.38% above the market average57.38% above the market average
53.68% above the sector average53.68% above the sector average53.68% above the sector average53.68% above the sector average53.68% above the sector average

Angle Dividends

No dividends found

Trades for 24-Dec-2024

Time Volume / Share Price
11:29 1,647 @ 9.20p
11:09 25,000 @ 9.43p
11:09 50,000 @ 9.43p
09:15 1,412 @ 9.77p
08:42 10,000 @ 9.68p

Angle Key Personnel

CEO Andrew D Newland
Finance Director Ian F Griffiths
Chair Jan Groen

Top of Page